Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jun 5;15(11):3055. doi: 10.3390/cancers15113055

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

An overview of cardiovascular complications caused by various cancer therapies. There exists a plethora of acknowledged cardiovascular side effects associated with cancer treatments. Pan-cancer therapies encompass a range of treatments, including classic chemotherapeutic agents, targeted drugs, immuno-oncology agents, and radiotherapy, each impacting various aspects of the cardiovascular system through distinct mechanisms. CAR, chimeric antigen receptor; Her-2, human epidermal growth factor receptor-2; HF, heart failure; ICI, immune checkpoint inhibitor; LV, left ventricular; MI, myocardial infarction; TKI, tyrosine kinase inhibitor; VEGF, epithelial growth factor receptor.